Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-25

Clinical Trial Update: Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury [Phase 3]

View source ↗

Summary

This Phase 3 study evaluated tadalafil for erectile dysfunction caused by spinal cord injury and has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Erectile Dysfunction, Spinal Cord Injuries | Phase 3 | Status: COMPLETED